MDT

86.12

-0.35%↓

A

114.52

+0.38%↑

VEEV

172.86

-1.39%↓

HQY

83.5

-0.08%↓

PHR.US

8.32

+0.73%↑

MDT

86.12

-0.35%↓

A

114.52

+0.38%↑

VEEV

172.86

-1.39%↓

HQY

83.5

-0.08%↓

PHR.US

8.32

+0.73%↑

MDT

86.12

-0.35%↓

A

114.52

+0.38%↑

VEEV

172.86

-1.39%↓

HQY

83.5

-0.08%↓

PHR.US

8.32

+0.73%↑

MDT

86.12

-0.35%↓

A

114.52

+0.38%↑

VEEV

172.86

-1.39%↓

HQY

83.5

-0.08%↓

PHR.US

8.32

+0.73%↑

MDT

86.12

-0.35%↓

A

114.52

+0.38%↑

VEEV

172.86

-1.39%↓

HQY

83.5

-0.08%↓

PHR.US

8.32

+0.73%↑

Search

Inspire Medical Systems Inc

Deschisă

SectorSănătate

53.32 5.02

Rezumat

Modificarea prețului

24h

Curent

Minim

50.37

Maxim

54.94

Indicatori cheie

By Trading Economics

Venit

126M

136M

Vânzări

45M

269M

P/E

Medie Sector

10.309

56.063

Marjă de profit

50.577

Angajați

1,333

EBITDA

33M

50M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+49.48% upside

Dividende

By Dow Jones

Următoarele câștiguri

4 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-510M

1.5B

Deschiderea anterioară

48.3

Închiderea anterioară

53.32

Sentimentul știrilor

By Acuity

25%

75%

71 / 349 Clasament în Healthcare

Inspire Medical Systems Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

31 mar. 2026, 23:31 UTC

Acțiuni populare

Stocks to Watch: Nike, RH, NCino

31 mar. 2026, 22:35 UTC

Câștiguri

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1 apr. 2026, 00:00 UTC

Achiziții, Fuziuni, Preluări

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31 mar. 2026, 23:50 UTC

Achiziții, Fuziuni, Preluări

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31 mar. 2026, 23:43 UTC

Market Talk

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31 mar. 2026, 23:33 UTC

Market Talk
Evenimente importante

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31 mar. 2026, 23:21 UTC

Câștiguri

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31 mar. 2026, 23:14 UTC

Market Talk
Câștiguri

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31 mar. 2026, 23:12 UTC

Market Talk

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31 mar. 2026, 22:36 UTC

Câștiguri

China Vanke 2025 Loss Widens >000002.SZ

31 mar. 2026, 22:36 UTC

Câștiguri

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31 mar. 2026, 22:36 UTC

Câștiguri

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31 mar. 2026, 22:36 UTC

Câștiguri

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31 mar. 2026, 22:36 UTC

Câștiguri

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31 mar. 2026, 21:46 UTC

Achiziții, Fuziuni, Preluări

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31 mar. 2026, 21:36 UTC

Market Talk

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31 mar. 2026, 21:35 UTC

Câștiguri

Nike Expects China Sales Down 20% in 4Q, CFO Says

31 mar. 2026, 21:35 UTC

Câștiguri

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31 mar. 2026, 21:35 UTC

Câștiguri

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31 mar. 2026, 21:33 UTC

Achiziții, Fuziuni, Preluări

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31 mar. 2026, 21:33 UTC

Câștiguri

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31 mar. 2026, 21:32 UTC

Câștiguri

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31 mar. 2026, 21:28 UTC

Câștiguri

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31 mar. 2026, 21:26 UTC

Câștiguri

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31 mar. 2026, 21:25 UTC

Câștiguri

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31 mar. 2026, 21:24 UTC

Market Talk
Câștiguri

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31 mar. 2026, 21:22 UTC

Câștiguri

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31 mar. 2026, 21:22 UTC

Câștiguri

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31 mar. 2026, 21:21 UTC

Câștiguri

Nike's Digital Channel Still Too Promotional, CFO Says

31 mar. 2026, 21:20 UTC

Câștiguri

Nike CEO: Converse Remains Important to Portfolio

Comparație

Modificare preț

Inspire Medical Systems Inc Așteptări

Obiectiv de preț

By TipRanks

49.48% sus

Prognoză pe 12 luni

Medie 77.1 USD  49.48%

Maxim 125 USD

Minim 60 USD

În baza a 15 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruInspire Medical Systems Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

15 ratings

4

Cumpărare

11

Păstrare

0

Vânzare

Sentiment

By Acuity

71 / 349 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Inspire Medical Systems Inc

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
help-icon Live chat